:max_bytes(150000):strip_icc()/GettyImages-2196063137-d33ea240a79542a48f498e1da92cc39f.jpg?w=780&resize=780,470&ssl=1 "Apple, AbbVie, Deckers Outdoor, and More")
Key Takeaways U.S. equities were mostly higher at midday on positive tech earnings news and a report showing December inflation…
Read More »AbbVie
:max_bytes(150000):strip_icc()/GettyImages-1970099302-41bb08e8e83543a4854b6ba0bab4c244.jpg?w=780&resize=780,470&ssl=1 "AbbVie Stock Soars as Biotech Tops Sales Estimates, Raises Outlook")
Key Takeaways AbbVie’s fourth-quarter revenue exceeded forecasts on higher sales of its Skyrizi and Rinvoq drugs to treat inflammation. The…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2184833968-7c355e309d3c47f5afb4848e49053a41.jpg?w=780&resize=780,470&ssl=1 "AbbVie Takes .5B Impairment Charge for Failed Schizophrenia Drug")
Key Takeaways AbbVie said it would take a $3.5 billion dollar impairment charge related to the failure of a drug…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2172784450-f3019c75fc0a4b74954a38833c0a69ca.jpg?w=780&resize=780,470&ssl=1 "AbbVie Stock Sinks After Schizophrenia Drug Trials Disappoint")
Key Takeaways Shares of AbbVie plummeted Monday after the company said its schizophrenia drug Emraclidine missed key goals in a…
Read More »